Found 64 matching trials
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
PHASE2RATIONALE: Antineoplastons are naturally-occurring substances that may also...
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
PHASE2RATIONALE: Current therapies for adults with primary malignant brain tumors...
Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
PHASE2Current therapies for Stage IV Pancreatic Cancer provide very limited benef...
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
PHASE2Current therapies for Refractory Stage IV Prostate Cancer provide very limi...
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
PHASE2RATIONALE: Antineoplastons are naturally-occurring substances that may also...
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
PHASE2Current therapies for Cancer of Unknown Primary Origin provide very limited...
Antineoplaston Therapy in Treating Patients With Multiple Myeloma
PHASE2Current therapies for Multiple Myeloma provide limited benefit to the patie...
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
PHASE2Current therapies for Recurrent or Stage IV Lung Cancer provide very limite...
Antineoplaston Therapy in Treating Patients With Meningioma
PHASE2RATIONALE: Current therapies for adults with meningioma provide limited ben...
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
PHASE2Current therapies for metastatic or unresectable Colon Cancer provide very ...